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Objective. To assess levels of physical activity the use of objective physical activity measures like accelerom-
eters is promising. We investigated characteristics associated with non-participation in accelerometry within
an apparently healthy sample.
Methods. Among German participants of a cardiovascular examination program (CEP; 2012–2013), 470 par-
ticipants aged 40–75 years were invited to wear an accelerometer for 7 days. We used multivariate logistic re-
gression to estimate the association between non-participation and the following characteristics of
participants: sex, age, education, smoking, setting of recruitment for the CEP (generalmedical practices, job agen-
cies, statutory health insurance), self-reported general health, and objective health criteria such as cardiorespira-
tory ﬁtness and absolute number of cardiometabolic risk factors (elevated waist circumference, blood pressure,
triglycerides, blood glucose, and reduced high-density lipoprotein). Subsequently, we stratiﬁed this analysis by
sex.
Results. Among all invited individuals, N= 235 (60.0%women) gave consent to participate in accelerometry.
Womenweremore likely to decline participation (odds ratio, 1.7; 95% conﬁdence interval, 1.1–2.7) compared to
men. Stratiﬁed analyses revealed the absolute number of risk factors as predictor of non-participation for men
(1.4; 1.01–2.0), while there was no predictor found in women.
Conclusion.We found a self-selection bias in participation in accelerometry.Women declined study participa-
tionmore likely thanmen. The number of cardiometabolic risk factors decreased compliance only inmen. Future
studies should consider strategies to reduce this bias.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Measurement of physical activity is relevant for a variety of studies
such as intervention studies aiming to enhance physical activity to re-
duce cardiovascular risks. Self-reported levels of physical activity differ
substantially from directly measured levels of physical activity (Prince
et al., 2008; Troiano et al., 2008). To assess physical activity accurately
within populations or to evaluate precisely the effectiveness of
interventions addressing physical activity the use of objective physical
activity measures is seen as optimal by now (Davis and Fox, 2007;
Prince et al., 2008; Reilly et al., 2008).
Objective measures, like accelerometric motion sensors, have
the advantages to reduce reporting bias (Reilly et al., 2008) and recallald, Institute of Social Medicine
fswald, Germany.
(F. Weymar).
. This is an open access article underbias (Brown and Werner, 2008). However, disadvantages include the
possibility to increase selection bias, the self-selection of individuals to
participate in a study. The use of accelerometers as assessment tools im-
plies, for example, a higher burden for study participants compared to
surveys and may lead to non-participation for different groups. So far
only few studies investigated characteristics associated with consent
to participate in an accelerometer study (Harris et al., 2008) or associat-
edwith valid participation inwearing an accelerometer according to the
study protocol (4–7 days, 10 h per day; Inoue et al., 2010; Roth and
Mindell, 2013). Analyses from Harris et al. (2008) revealed that partici-
pants 65 years of age or older who agreed to participate in an acceler-
ometer study are more likely to be male, to have higher levels of
physical activity, and to report poorer health, e.g., chronic pain or chron-
ic diseases. To our knowledge, no study investigated differences be-
tween participants who agreed to participate in an accelerometer
study and non-participants with respect to objectively assessed health
criteria such as cardiorespiratory ﬁtness (CRF) and the presence of car-
diometabolic risk factors. Lower CRF measured as peak oxygen uptakethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Flow of participation; CEP, cardiovascular examination program (Germany,
2012–2013). *Ineligibility criteria: history of cardiovascular events (myocardial infarction,
stroke), vascular interventions, diabetes mellitus, self-reported body mass index (BMI)
N35 kg/m2, previousMethicillin-resistant Staphylococcus aureus (MRSA) infection, no res-
ident in a pre-deﬁned zip-code area.
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reported physical activity and a higher likelihood to show an unfavor-
able cardiovascular risk proﬁle (Aspenes et al., 2011). Cardiometabolic
risk factors that are also considered for the deﬁnition of the metabolic
syndrome, such as elevated waist circumference, blood pressure, tri-
glycerides, or blood glucose, and reduced high-density lipoprotein, are
associated with a high risk for cardiovascular diseases (CVD) (Grundy
et al., 2005).
Our purpose was to identify variables that are associated with non-
participation in wearing an accelerometer for 7 days in a sample of sub-
jects recruited from the general population, who already participated in
a cardiovascular examination program. We considered objective health
criteria such as objectively measurable cardiometabolic risk factors and
CRF as well as parameters that have been previously considered as pre-
dictors for non-participation in accelerometer studies such as self-
reported general health, smoking status, and socio-demographic
variables.
Methods
Study population and design
This study was part in a series of studies to investigate reach of
different German population groups (Glasgow et al., 1999) within a
stepwise provided screening and examination program addressing
cardiovascular health. Participants were recruited between June 2012
and December 2013 by different strategies in three settings (personal
contact between study nurses and patients aged 40–75 years in general
practices, clients aged 40–65 years in job agencies; at random invitation
by letter of a statutory health insurer in a health insured population
aged 40–75 years). The settings are described more precisely below.
Recruitment of study participants included three steps. A total of 1150
individuals participated in a health screening (step 1) and completed
a computerized questionnaire on cardiovascular risk factors, followed
by facultative blood pressure measurement and blood sample taking.
Furthermore, participants with characteristics as listed below were eli-
gible for a cardiovascular examination program(CEP; step 2): nohistory
of cardiovascular events (myocardial infarction, stroke), vascular inter-
ventions, or diabetes mellitus as well as self-reported body mass index
(BMI) ≤35 kg/m2, no previous Methicillin-resistant Staphylococcus
aureus (MRSA) infection and resident in a pre-deﬁned zip-code area.
A total of 706 participants of the health screening were eligible for
the CEP. Of these, 582 individuals (82.4%) participated in the CEP. It
was conducted at the University hospital by trained study nurses and
was supervised by study physicians. At the beginning of the CEP partic-
ipants were informed about the modules of examination (e.g., blood
pressure measurement, blood taking), data storage, and about the
handling of potential medical ﬁndings. Accelerometry was offered as a
further examination (step 3). Participantswere providedwith the infor-
mation that physical activity would be recorded for 7 days by an accel-
eration sensor (ActiGraph, GT3X+), a small box on a belt that would
have to be worn around the hip. Additionally, they were informed that
a physical activity diary would have to be ﬁlled out during accelerome-
ter wear time (capturing activity, time interval, and perceived effort).
Finally, participants received the information that a written feedback
about their physical activity would be provided. All individuals gave
written informed consent for each examination separately. Detailed
information concerning accelerometry, such as instructions for wearing
the accelerometer, was given at the end of the CEPwhen participants re-
ceived the device. Due to organizational reasons the accelerometer study
was implemented with a temporal delay. Therefore, accelerometry was
only offered to 470 participants (see Fig. 1). For each step of the study,
participants could choose one of different gift vouchers for different
shopping facilitiesworth€5 (step 1), €15 (step 2), and €15 (step 3). Par-
ticipants in the accelerometer study had to return their accelerometer
and the physical activity diary at the university hospital to receivetheir last gift voucher. This study was approved by the clinical ethical
committee of the University Medicine Greifswald (protocol number
BB64/07).
Settings of recruitment
Participantswere recruited in three different settings: in general prac-
tices, in job agencies, and by a statutory health insurance. In Germany, job
agencies are responsible for the implementation of basic security beneﬁts
for job seekers following the social security code. Regarding our statutory
health insurance population, in Germany, employees up to a certain in-
come limit (in 2013: 52.200 € gross annual income) are obliged to insure
themselves in a statutory health insurance of their own choice. People
who are not employed, e.g., self-employed persons, have the option to in-
sure themselves in a statutory or in a private health insurance.
Measures
Socio-demographics and smoking
We collected information about sex, age, school education (common
German types of school education; categorized as b10 years, 10 years,
N10 years for international comparability), and current smoking (yes/no).
Self-reported general health
Self-reported general health wasmeasured with the ﬁrst item of the
SF-36 Health Survey “In general, would you say your health is…” using
a 5-point scale (excellent, very good, good, fair, poor) (McHorney et al.,
1994).
Cardiorespiratory ﬁtness
Cardiorespiratory ﬁtness (CRF) was assessed on a cycle ergometer
(Ergoselect 100; Ergoline, Bitz, Germany) via standardized
cardiopulmonary exercise testing according to the Jones protocol
(Jones et al., 1985). CRF was deﬁned by peak oxygen uptake (V

O2peak).
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where (Koch et al., 2009). For main analyses, relative V

O2peak was
used. Relative V

O2peak was calculated as absolute V

O2peak divided
by body weight. For secondary analyses, V

O2peak expressed in
percentages of the predicted values was used. Calculation of the pre-
dicted values was based on a SHIP equation from Gläser et al. (2013),
which is based on a sample from our study region (northeast
Germany).
Assessment of cardiometabolic risk factors
The following ﬁve parameters were considered for further analyses of
cardiometabolic risk: elevated waist circumference, elevated resting
blood pressure, elevated triglycerides, elevated blood glucose, and re-
duced high-density lipoprotein. These ﬁve factors constitute themetabol-
ic syndrome (Grundy et al., 2005). Waist circumference was measured
midway between the hipbone and the bottom of the ribs. Waist circum-
ference was considered elevated if ≥102 cm for males or ≥88 cm for fe-
males (WHO, 2000). Systolic and diastolic blood pressure were
measured after a ﬁve minute rest period three times at the right arm of
seated participants using a digital blood pressure monitor (705IT,
Omron Corporation, Tokyo, Japan), with each reading being followed by
a further rest period of threeminutes . Themean of the 2nd and 3rdmea-
surements was used for the present analyses. Blood pressure was consid-
ered elevated if one ormore of the three conditionsweremet: (1) systolic
pressure ≥140 mm Hg, (2) diastolic pressure ≥90 mm Hg (Mancia et al.,
2013), and (3) self-reported antihypertensive medication within the
last 12 months. Blood samples were taken all-day in a non-fasting state.
Glycated hemoglobin (HbA1c), high-density lipoprotein (HDL), and plas-
ma triglycerides were determined by standard methodology at the clini-
cal chemistry laboratories at the University Medicine Greifswald. HbA1c
was used for analyses instead of blood glucose because sampleswere col-
lected in the non-fasted state and glucose levels would be inaccurate.
HbA1c was considered elevated at N6.5% (WHO, 2011). HDL was consid-
ered reduced at b50 mg/dL in women or b40 mg/dL in men (Grundy
et al., 2005). To account for non-fasted blood samples, triglycerides
were considered elevated at ≥200 mg/dL (Wannamethee et al., 2005).
Wedidnot take into account if participants reportedblood lipids lowering
medicationwithin the last 12months becausewe did not ask participants
for the exact kind of their medication. Therefore, we could not be certain
whether the medication had an impact on HDL and/or triglycerides or
not.
Data analysis
Analyses were performed using STATA 12.1 (StataCorp, 2011). We
used multivariate logistic regression to generate odds ratios (OR) and
95% conﬁdence intervals (CI) to estimate the association between non-
participation in the accelerometer study and the following characteristics
of participants: sex, age, education, current smoking, self-reported gener-
al health, CRF, number of cardiometabolic risk factors, and setting of re-
cruitment. Subsequently, we stratiﬁed this analysis by sex. Finally, we
used logistic regression to calculateORof non-participation in the acceler-
ometer study for each of the objectively measured cardiometabolic risk
factors separately, stratiﬁed by sex. Models were adjusted for age, CRF,
and setting of recruitment.
Results
Among participants of the CEP who had been invited to take part in
the accelerometer study [n = 470; 64.7% women; mean age 56.3 years
(SD=10.0)], 235 participants (50%; 60.0%women) agreed towear an ac-
celerometer for 7 days. Table 1 shows the characteristics of accelerometer
study participants and non-participants stratiﬁed by sex. The distribution
of the number of cardiometabolic risk factors is shown in Fig. 2.Multivariate logistic regression analysis with all predictor variables
entered including a composite measure of cardiometabolic risk factors
(number of cardiometabolic risk factors) revealed (Table 2) that
women were more likely to decline participation (OR = 1.7, 95% CI =
1.06–2.74) compared tomen. Setting of recruitment did not predict accel-
erometer study participation. Stratiﬁed analyses (Table 2) revealed the
number of risk factors as predictor of non-participation for men (OR =
1.4, 95% CI= 1.01–1.95). Women did not differ on any entered variables.
Considering the cardiometabolic risk factors separately, Table 3 shows
results from logistic regression analyses adjusted for age, CRF, and setting
of recruitment. Men with elevated blood pressure tended to decline par-
ticipation more likely (OR = 1.9, 95% CI = 0.94–3.7) compared to men
with normal blood pressure values, even though this result barelymissed
statistical signiﬁcance (p= 0.07). Among women, those with elevated
waist circumference were less likely to decline participation (OR = 0.6,
95% CI = 0.3–0.95) compared to women with values below the
predeﬁned cut-off of 88 cm.
Secondary analyses in which V

O2peak expressed in percent of pre-
dicted values was used for all analyses yielded similar results.Discussion
The three main ﬁndings of our study were that (1) more women
declined participation in accelerometry than men, (2) men were more
likely not to participate in the study if they had a higher number of car-
diometabolic risk factors, and (3) waist circumference was negatively
associated with non-participation for women.
Accelerometer study participantsweremore likelymen. Thisﬁnding
supports results from Harris et al. (2008) for a sample of a comparable
sample size of participants 65 years of age or older registeredwith a pri-
mary health care center and recruited by different recruitment
strategies.
Menwith higher cardiometabolic riskweremore likely to decline par-
ticipation. We assume that men of higher cardiovascular risk are already
aware that they need to be more physically active to reduce their CVD
risk (Pikala et al., 2011). Thus, these men might not see it as necessary
or helpful to wear an accelerometer to get possibly known low levels of
physical activity conﬁrmed. Moreover, declining participation might also
be information avoidance, behavior to prevent people from obtaining po-
tentially unwanted information, such as non-participation in the acceler-
ometer study to avoid unpleasant feelings based on expected negative
feedback (Sweeny et al., 2010). In contrast, the CVD risk in women
seemed to be lower compared to men (three or more risk factors: 16%
inwomen vs. 24%men),whichmight explainwhy the number of risk fac-
tors does not predict non-participation in women.
Women declined participation more likely when their waist circum-
ferencewas normal. A possible explanation for the association of elevated
waist circumference and less rejection of study participation by women
might be that women with normal waist circumference are more likely
to be already physically active, and therefore do not see the necessity to
get examined regarding their physical activity.
Further, our results revealed that CRF was not associated with non-
participation in the accelerometer study. Prior research showed higher
self-reported physical activity in accelerometer study participants com-
pared to non-participants (Harris et al., 2008). However, we could not
ﬁnd differences in CRF as a proxy measure of physical activity.
Although we did not ask for reasons for non-participation, different
barriers could be imagined. For example, peoplemight see it impractical
to wear an accelerometer because they have to remember to wear it for
seven days, they have to take care of it (no showering, no swimming), it
might be uncomfortable to wear it, etc. Furthermore, people might as-
sociate wearing of this device with unpleasant feelings because other
people could see the accelerometer, it could get wet through with per-
spiration, it might inﬂuence sexual life, people may feel monitored or
might not be interested in a potential negative feedback about their
Table 1
Characteristics of study population stratiﬁed by sex and accelerometer study participation (Germany, 2012–2013).
Women Men
Participants (n = 141) Non-participants (n = 163) p Participants (n = 94) Non-participants (n = 72) p
Sociodemographic variables
Age (years) 56.26 (9.38) 56.70 (10.33) ns 56.60 (9.79) 54.81 (10.43) ns
Education (years) ns ns
≤10 (%) 11.35 14.37 19.35 13.89
=10 (%) 51.77 50.00 47.31 55.56
≥10 (%) 36.88 35.63 33.33 30.56
No information (n = 4)
Current smoker (yes, %) 22.70 22.09 ns 25.53 33.33 ns
Self-reported health variable
Self-reported general health 3.05 (0.66) 3.09 (0.72) ns 2.95 (0.81) 3.01 (0.62) ns
Objective health variables
V

O2peak(mL∙kg
−1∙min−1) 24.12 (5.21) 24.41 (6.07) ns 29.31 (6.53) 28.71 (7.15) ns
No information (n = 8)
Number of cardiometabolic risk factors 1.26 (1.21) 1.28 (1.19) ns 1.46 (1.09) 1.95 (1.33) .01
No information (n = 42)
Single cardiometabolic risk factors
Elevated waist circumference (yes, %) 46.10 36.02 ns 35.11 45.07 ns
No information (n = 3)
Reduced high-density lipoprotein (yes, %) 20.30 27.52 ns 30.68 34.38 ns
No information (n = 36)
Elevated triglycerides (yes, %) 15.79 17.45 ns 32.95 45.31 ns
No information (n = 36)
Elevated blood pressure or meds (yes, %) 41.13 44.38 ns 46.24 61.11 ns
No information (n = 4)
Elevated HbA1c (yes, %) 3.01 2.03 ns 2.30 6.15 ns
No information (n = 37)
Blood lipids lowering meds (yes, %) 9.22 7.36 ns 11.70 12.50 ns
Blood pressure lowering meds (yes, %) 34.04 35.58 ns 26.60 36.11 ns
Setting of recruitment ns ns
General practices (%) 32.62 36.20 41.49 36.11
Job agencies (%) 17.02 16.56 21.28 29.17
Health insurance (%) 50.35 47.24 37.23 34.72
Abbreviations: V

O2peak, cardiorespiratory ﬁtness measured as maximum oxygen uptake; HbA1c, glycated hemoglobin.
Data are presented asmean± SD for continuous variables and as the number of subjects (%) for categorical variables; presented p-values are based on t-test for continuous variables and
chi-square test for categorical variables.
416 F. Weymar et al. / Preventive Medicine Reports 2 (2015) 413–418physical activity and avoid it by declining participation (information
avoidance). Moreover, participating in the accelerometer study was a
higher burden for participants because they had to bring the device
back to the University hospital and were asked to complete a diary. Fu-
ture research should address these questions to enhance participation
in accelerometer studies. Findings about reasons, why people do not
want to wear devices like accelerometers can give hints about
necessary changes in, e.g., selections of kinds of devices, instructions
or motivational strategies.
An important limitation of our studywas the pre-selection occurring
in earlier steps before our accelerometer study (see Fig. 1). We had no
information on people who did not want to participate in the health
screening and we had just limited information on people who were
not interested to participate in the CEP. For example, prior analyses of
subpopulations of our study population proved earlier occurringFig. 2. Distribution of number of cardiometabolic risk factors by sex (Germanyselection biases, e.g., non-smoking predicted participation in the CEP
within the general practice patients sample as well as in the job agency
client sample (Guertler et al., 2014). Moreover, we had a restricted sam-
ple according health because people of poorer health, such as individ-
uals with prior CVD, self-reported BMI N35 kg/m2, or diabetes, were
not eligible for the CEP. Results cannot be generalized to a non-
restricted sample.
Despite these limitations, our results have potential implications for
future research using objective measures for physical activity like accel-
erometers because we found a selection bias according to sex and in
men regarding their cardiometabolic risk factor proﬁle. These aspects
need to be considered in planning of future studies or in interpretation
and generalization of future research results.
In conclusion, selection bias in accelerometer study participation
was observed. Women were less likely to participate in accelerometry, 2012–2013). *p b .05; the chi-square test was used to compare groups.
Table 2
Characteristics associated with non-participation in a 7-day accelerometer study (Germany, 2012–2013).
Overall (n = 411) Women (n = 267) Men (n = 144)
Odds ratioa 95% CI Odds ratioa 95% CI Odds ratioa 95% CI
Sex
Men Ref.
Women 1.70 (1.06–2.74)⁎
Age 1.00 (0.98–1.03) 1.01 (0.98–1.05) 0.98 (0.94–1.03)
Education
Less than 10 years Ref. Ref. Ref.
10 years 0.95 (0.50–1.80) 0.81 (0.35–1.85) 1.07 (0.37–3.12)
More than 10 years 0.87 (0.45–1.67) 0.69 (0.30–1.60) 1.37 (0.46–4.09)
Current smoker
Yes Ref. Ref. Ref.
No 0.96 (0.58–1.60) 0.98 (0.52–1.85) 1.09 (0.44–2.70)
Self-reported general health 1.08 (0.81–1.44) 1.11 (0.76–1.62) 1.17 (0.73–1.86)
V

O2peak (mL∙kg
−1∙min−1) 1.01 (0.97–1.06) 1.04 (0.98–1.10) 0.99 (0.93–1.05)
Number of cardiometabolic risk factors 1.11 (0.92–1.33) 1.01 (0.81–1.26) 1.40 (1.01–1.95)⁎
Setting of recruitment
General practices Ref. Ref. Ref.
Job agencies 1.13 (0.64–1.99) 0.90 (0.43–1.88) 1.65 (0.64–4.30)
Health insurance 0.98 (0.62–1.57) 0.92 (0.52–1.63) 1.04 (0.43–2.53)
Abbreviation: V

O2peak, cardiorespiratory ﬁtness measured as maximum oxygen uptake.
a Odds ratios were adjusted for all other variables shown in the table.
⁎ p b 0.05.
417F. Weymar et al. / Preventive Medicine Reports 2 (2015) 413–418than men. Men were less likely to participate if they faced a higher car-
diometabolic risk than if they had a lower risk. Especially the men at
high risk would be the target group of primary interest in interventions
aiming to reduce cardiovascular risks. Interventions addressing the en-
hancement of physical activity using accelerometers need to consider
possible selection bias during recruitment and need to develop strate-
gies to reduce this bias.
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